Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India

Tubercle and Lung Disease

Volumn 79, Issue 5, 1999, Pages 309-317

  Ravikumar, M ^c   Dheenadhayalan, V ^c   Rajaram, K ^a   Shanmuga Lakshmi, S ^c   Paul Kumaran, P ^a   Paramasivan, C N ^b   Balakrishnan, K ^c   Pitchappan, R M ^c  

^a Government Rajaji Hospital   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PRIMER DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DETERMINATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOLOGY; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; SPUTUM;

EID: 0032833153     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1999.0213     Document Type: Article

References (49)

1. Pitchappan R M. Genetics of tuberculosis susceptibility. Trop Med Parasitol. 41:1990;355-356.
2. Singh S P N, Mehra N K, Dingley H B, Pande J N, Vaidya M C. Human leukocyte antigen (HLA) linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis. 148:1983;676-681.
3. Bothamley G H, Swanson-Beck J, Schreuder G M T. Association of tuberculosis and Mycobacterium tuberculosis specific-antibody levels with HLA. J Infect Dis. 159:1989;549-555.
4. Bothamley G H, Schreuder G M T, Vries R R P, Ivanyi J. Association of antibody responses to the 19kDa antigen of Mycobacterium tuberculosis and the HLA DQ locus. J Infect Dis. 167:1993;992-993.
5. Khomenko A G, Litvino V I, Chukanova V P, Pospelov L E. Tuberculosis in patients with various HLA phenotypes. Tubercle. 71:1990;187-192.
6. Brahmajothi V, Pitchappan R M, Kakkanaiah V N. Association of pulmonary tuberculosis and HLA in south India. Tubercle. 72:1991;123-132.
7. Bothamley G H, Schreuder G M T. Human leukocyte antigen, Tuberculosis and Mycobacterium tuberculosis -specific antibody. J Infect Dis. 165:1992;598.
8. Selvaraj P, Reetha A M, Uma H. Influence of HLA-DR and -DQ phenotypes on tuberculin reactive status in pulmonary tuberculosis patients. Tubercle Lung Dis. 77:1996;369-373.
9. Al-Arif L I, Goldstein R A, Affronti L F, Janicki B W. HLA Bw15 and tuberculosis in a North American Black population. Am Rev Respir Dis. 120:1979;1275-1278.
10. Hawkins B R, Higgins D A, Chan S L, Lowrie D B, Mitchison D A, Girling D J. HLA typing in a Hong Kong chest service/British Medical Research Council. Study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis. 138:1988;1616-1621.
11. Hafex M, El-Salab S H, El-Shennaway F, Bassiony M R. HLA antigens and tuberculosis in Egyptian population. Tubercle. 66:1985;35-40.
12. Hwang C H, Khan S, Ende N, Mangura B T, Reichman L B, Chou J. The HLA-A, -B and -DR phenotypes and tuberculosis. Am Rev Respir Dis. 132:1985;382-385.
13. Cox R A, Downs M, Neimes R E, Ornibene A J, Yamashita T S, Ellner J J. Immunogenetic analysis of human tuberculosis. J Infect Dis. 158:1988;1302-1308.
14. Saiki R K, Bugawan T L, Horn G T, Mullis K B, Erlich H A. Analysis of enzymatically amplified B-globulin and HLA-DQ alpha-DNA with allele specific probes. Nature. 324:1986;163.
15. Mehra N K, Bouwens A G M, Naipal A. Asian Indian HLA-DR2, DR4 and DR52 related DR-DQ genotypes analysed by PCR based non-radioactive oligonucleotide typing: unique haplotypes and a novel DR4 subtype. Hum Immunol. 39:1994;202-210.
16. Rajalingam R, Mehra N K, Jain R C, Myneedu V P, Pande J N. Polymerase chain reaction-based sequence specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis. 173:1996;669-676.
17. Shaw S, Johnson A, Shearer G. Evidence for a new segregant series of B cell antigens that are encoded in the HLA D region and that stimulate secondary allogenic proliferative and cytotoxic responses. J Exp Med. 152:1980;565-580.
18. Davies J L, Kawaguchi Y, Bennett S T. Genome wide search for Human type I Diabetes susceptibility genes. Nature. 371:1994;130-136.
19. Thorsby E. HLA associated diseases. Hum Immunol. 53:1997;1-11.
20. Holst E, Mitchison D A, Radhakrishnan S. Examination of smears for tubercle bacilli by flourescence microscopy. Indian J Med Res. 47:1959;495-496.
21. Sasazuki, T, Kimura, A, XI International Histocompatibility Workshop Conference manual.
22. Bignon J D, Fernandez-Vina M A. Protocols of the 12th IHW for PCR-SSOP. Charon D. Genetic diversity of HLA: functional and medical implication. 1997;584-595 EDK publishers, Paris.
23. Pitchappan R M, Arulraj N. A versatile computer database for human immunogenetics studies. Indian J Physiol Anthropol Human Genet. 15:1989;81-92.
24. Haldane J B S. The estimation and significance of the logrithm of a ratio of frequencies. Ann Hum Genet. 20:1956;309-311.
25. Rothman K J. 'Modern epidemiology'. 1986;Little Brown & Co. Boston. p. 163.
26. Green A. The epidemiological approach to the studies of association between HLA and disease II. Estimation of absolute risks, etiologic and preventive fraction. Tissue Antigens. 19:1982;259-268.
27. Mattiuz, P, L, Ihde, D, Piazza, A, Ceppellini, R, Bodmer, W, F, New approaches to the population genetic and segregration analysis of the HLA system, Terasaki, Histocompatibility Testing 1970, 193, 205.
28. Rammensee H G. Allele specific peptide motifs of HLA molecules. Charron D. Genetic diversity of HLA: functional and medical implication. 1997;35-38 EDK publishers, Paris.
29. Singal D P, D'Sousa M, Sood S K. Polymorphism of HLA-DR2, DQW1 haplotypes in Asian Indians. Tissue Antigens. 36:1990;164-170.
30. Clayton, J, Lonjou, C, Whittal, D, Allele and haplotype frequencies for HLA loci in various ethnic groups: Appendix B; section 2, Charron, D, Genetic diversity of HLA: function and medical implication, EDK publishers, Paris, 1997, 1, 725, 760.
31. Klaster P R, Janson A M, Thole J E. Humoral and cellular reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Int J Lepr Other Mycobact Dis. 65:1997;178-189.
32. Soebono H, Giphart M J, Schreuder G M, Klaster P R, De Vries R R. Associations between HLA-DRB1 alleles and leprosy in Indonesian population. Int J Lepr Other Mycobact Dis. 65:1997;190-196.
33. Roy S, McGuire W, Mascie-laylor C G. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Inf Dis. 76:1997;530-532.
34. Rani R, Fernandez-Vina M A, Zaheer S A, Beena K R, Stastny P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens. 42:1993;133-137.
35. Joko S, Numaga J, Masuda K, Namisato M, Maeda H. HLA-class II alleles and leprosy (Hansen's disease) classified by WHO-MDT criteria. Nippon Rai Gakkai Zasshi. 65:1996;121-127.
36. Kim J, Sette A, Rodda S. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J Immunol. 159:1997;335-343.
37. Hill A V S, Elvin J, Willis A C. Molecular analysis of the association of HLA B53 and resistance to severe malaria. Nature. 360:1992;434-439.
38. Hirayama K, Matsushita S, Kikuchi I, Imach M, Ohta N, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigens in humans. Nature. 327:1987;426-430.
39. Ottenhoff T H M, Walford C, Nishimura Y, Reddy N B B, Sasazuki T. HLA-DQ molecules and the control of M. leprae -specific T cell unresponsiveness in lepromatous leprosy patients. Eur J Immunol. 20:1990;2347-2350.
40. Brahmajothi, V, Studies on HLA association in health and disease among selected groups of Tamil Nadu, Ph.D. Thesis, Madurai Kamaraj University, Madurai, 1990.
41. Dheenadhayalan, V, Ravikumar, M, Balakrishnan, K, Rajaram, K, Paul Kumaran, P, Pitchappan, R, M, MHC class II and Mycobacterium tuberculosis peptide induced in-vitro lympho-proliferative responses of pulmonary tuberculosis patients and controls from south India 1998 (in preparation).
42. Pitchappan R M, Kakkanaiah V N, Rajasekar R, Arulraj N, Muthkaruppan V R. HLA antigens in south India. I Major groups of Tamil Nadu. Tissue antigens. 24:1984;190-196.
43. Rajasekar R, Kakkanaiah V N, Pitchappan R M. HLA antigens in south India: II selected caste groups of Tamil Nadu. Tissue Antigens. 30:1987;113-118.
44. Pitchappan, R, M, Manickasundari, M, Kakkanaiah, V, N, HLA Antigens in Sourashtrans of Madurai, HLA in Asia-Oceania. 1986. Proceedings of the third Asia-Oceania Histocompatibility workshop and conference, Japan, Aizawa, M, Hokkaido University Press, Japan, 539, 542.
45. Pitchappan R M, Balakrishnan K, Sudarsen V. Sociobiology and HLA genetic polymorphisms in Hill tribes, the Irulas of the Nilgiri Hills and the Malayali of the Shevroy Hills, south India. Hum Biol. 69:1997;59-74.
46. Balakrishnan K, Pitchappan R M, Suzuki K, Sankar Kumar U, Santhakumari R, Tokunaga K. HLA affinities of Iyers, a Brahmin population of Tamil Nadu, South India. Hum Biol. 68:1996;523-537.
47. Pitchappan R M, Koteeswaran A, Kakkanaiah V N. HLA Bw57 and DR7 association with psoriasis vulgaris in south India. Tissue Antigens. 34:1989;133-137.
48. Zumla A, Grange J. Science, medicine and the future: Tuberculosis. BMJ. 14:1998;763-765.
49. Sanghvi L D, Balakrishnan V, Karve I. 'Biology of the people of Tamilnadu'. 1981;Indian society of Human Genetics and Indian Anthropological society, Pune and Calcutta.